iPSCdirect™ Healthy Control Human iPSC Line SCTi003-A

Single-use, maintenance-free human induced pluripotent stem cells, frozen

iPSCdirect™ Healthy Control Human iPSC Line SCTi003-A

Single-use, maintenance-free human induced pluripotent stem cells, frozen

From: 695 USD
Catalog #
(Select a product)
Single-use, maintenance-free human induced pluripotent stem cells, frozen
Add to Wish List

Product Advantages


  • Eliminate the need for PSC maintenance with monolayer cultures that are ready to differentiate 24 hours post-plating

  • Expect the same extensive quality control that meets or exceeds industry standards as for the parent cell line, SCTi003-A

  • Speed up your research with ready-to-use iPSCs in a high-density format compatible with a number of STEMdiff™ kits for differentiation

What's Included

  • iPSCdirect™ Healthy Control Human iPSCs, Line SCTi003-A (Catalog #200-0510)

Overview

Speed up your research with ready-to-use, single-cell format iPSCdirect™ human induced pluripotent stem cells (iPSCs). Highly consistent and robust, iPSCdirect™ cells enable you to avoid the cost and effort of developing and characterizing cell banks for your iPSC research, as well as the need for keeping iPSCs in long-term culture. Save time and reduce variability by starting with the same source of quality-control-tested iPSCs for each of your experiments. iPSCdirect™ cells can be used directly from thawing for iPSC-based screening or differentiation to various cell types.

iPSCdirect™ cells are specially cryopreserved from the iPSC control line, SCTi003-A. For optimal product performance, iPSCdirect™ is manufactured with our leading a href="/products/mtesr-plus.html">mTeSR™ Plus medium and optimized for monolayer-based differentiation protocols. It is compatible with several STEMdiff™ media products, including STEMdiff™ Ventricular Cardiomyocyte Differentiation Kit, STEMdiff™ SMADi Neural Induction Kit, and STEMdiff™ Hepatocyte Kit.

This research-use-only (RUO) product has been consented for both academic and commercial use. For donor details and cell quality characterization of the source cell banks, refer to the data figures on this page. For additional details, refer to the lot-specific Certificate of Analysis.
Contains
FreSR™-S
Subtype
Frozen
Cell Type
Pluripotent Stem Cells
Species
Human
Cell and Tissue Source
Pluripotent Stem Cells
Brand
STEMdiff, TeSR
Area of Interest
Disease Modeling, Drug Discovery and Toxicity Testing, Infectious Diseases, Neuroscience

Data Figures

Experimental protocol diagram for using iPSCdirect ready-to-use cells

Figure 1. Schematic for a Generalized Monolayer Protocol to Thaw and Culture iPSCdirect™ for iPSC-Based Monolayer Workflows

iPSCdirect™ cells can be thawed and plated into mTeSR™ Plus (Catalog #100-0276) supplemented with CloneR™2 (Catalog #100-0691) and incubated overnight according to product instructions. Recommendations for seeding densities to reach the desired confluency at 24 hours may be found in the Product Information Sheet. After 24 hours, cells are ready for STEMdiff™ or customized monolayer workflows. iPSC = induced pluripotent stem cell.

Microscopy images of iPSCdirect cells at low, medium, and high confluency after 24 hours

Figure 2. iPSCdirect™ SCTi003-A Cells Can Be Seeded to Reach a Range of Confluencies After 24 Hours

To reach the desired confluency for downstream experiments, thaw and plate iPSCdirect™ cells into mTeSR™ Plus with CloneR™2 (Catalog #100-0276 and #100-0691) at the densities recommended in the Product Information Sheet. These representative examples of (A) low confluency, (B) medium confluency, and (C) high confluency were cultured after thaw on Corning® Matrigel® hESC-Qualified Matrix and imaged at a magnification of 4X.

Table 1. iPSC Line SCTi003-A, the Source for iPSCdirect™ SCTi003-A, Is Derived from a Healthy Female Donor

Table compiling sex, ancestry, haplotype, and other donor information for the source cell line SCTi003-A

Demographic, health, and genetic characteristics of the SCTi003-A donor are compiled from self-reported information and whole-exome sequencing. Sex was determined by karyotype. Ancestry was calculated by EthSEQ analysis from whole-exome sequencing data. HLA haplotype was determined by next-generation sequencing, sequence-base typing, and sequence-specific oligonucleotide probes as needed to obtain the required resolution. Other genetic variants were determined from whole-exome sequencing using ClinVar analysis. Blood type (ABO/Rh blood group) was determined by next-generation sequencing. Height, weight, and BMI were calculated at the donation facility.

Typical human karyogram showing all chromosomes and no clonal abnormalities

Figure 3. iPSCdirect™ SCTi003-A Human Pluripotent Stem Cells Maintain a Typical Karyotype

G-T-L banding for thawed iPSCdirect™ cells (SCTi003-A p34, n = 40) shows a typical karyotype with no evidence of clonal abnormalities at a band resolution of 425 - 475 G-bands per haploid genome.

Data table presenting a list of chromosomal gains and losses determined by SNP microarray

Table 2. Single Nucleotide Polymorphism Microarray Analysis Characterizes iPSCdirect™ SCTi003-A Copy Number Variants Consistent with the Source Cell Line

DNA was extracted from a vial of iPSCdirect™ SCTi003-A iPSCs and subjected to SNP microarray analysis to identify large-scale copy number variants (CNVs). Consistent with the variants detected in the source SCTi003-A cell line (see Figure 4 of SCTi003-A product data), the thawed cells display two reportable CNVs, defined as those greater than 400kb in size, on chromosome 7 and 14 (rows highlighted in bold font). These losses are located in the TCR regions of the genome and are indicative of VDJ recombination process during T Cell development. Array design, genomics position, genes, and chromosome banding are based on genome build GRCh37/hg19. chr = chromosome; start cyto = cytogenetic band at the start of the base pair imbalance; end cyto = cytogenetic band at the end of the base pair imbalance; bp = base pairs; SNP = single nucleotide polymorphism; TCR = T Cell Receptor; VDJ = variable, diversity, joining segment.

Bar graph quantification of OCT3/4 and TRA-1-60 gene expression

Figure 4. iPSCdirect™ SCTi003-A Cells Express Undifferentiated Cell Markers

iPSCdirect™ SCTi003-A was characterized using flow cytometry for undifferentiated cell markers OCT3/4 and TRA-1-60. Percentage marker expression was quantified 4 days after thawing, from analyses of three biological replicates (n = 3 vials). Error bars represent the standard deviation.

Bar graph quantifying gene expression of 6 trilineage markers by flow cytometry

Figure 5. iPSCdirect™ SCTi003-A Human Pluripotent Stem Cells Demonstrate a High Trilineage Differentiation Capacity

iPSCdirect™ SCTi003-A cells were split into 3 groups, differentiated using STEMdiff™ Trilineage Differentiation Kit (Catalog #05230), and then subjected to flow cytometry analysis. Two markers for each embryonic germ layer were assessed, and bars represent mean marker expression for each group of cells (dots represent the average of 3 technical replicates; error bars represent standard deviation; n = 3 biological replicates). All lineage-specific markers were expressed by more than 70% of differentiated cells. Expression of PAX6 and Nestin confirm differentiation to the ectoderm lineage, NCAM and Brachyury (T) expression confirm differentiation to the mesoderm lineage, and CXCR4 and SOX17 expression confirm differentiation to the endoderm lineage.

Immunofluorescent images of 2 neural progenitor markers and a nuclear stain along with their quantification

Figure 6. iPSCdirect™ SCTi003-A Human Pluripotent Stem Cells Can Efficiently Differentiate into Neural Progenitor Cells Upon Thawing

NPCs were generated from iPSCdirect™ SCTi003-A cells using the protocol in the iPSCdirect™ Product Information Sheet followed by the monolayer protocol from Day 1 in the STEMdiff™ SMADi Neural Induction Kit Technical Manual (Catalog #08581). After the first 7 days of the protocol, the resulting NPCs were fixed for immunocytochemistry. The NPCs expressed neural progenitor markers (A) SOX1 and (B) PAX6, and nuclei were visualized with (C) DAPI. (D) Marker expression was quantified and negative control SOX10 expression was minimal. Error bars represent standard deviation (n = 2 biological replicates). NPCs = neural progenitor cells.

Microscopy images of iPSCdirect cells and differentiated ventral cardiomyocytes, and a video of coordinated contraction or beating behavior of cardiomyocytes in a culture dish

Figure 7. iPSCdirect™ SCTi003-A Human Pluripotent Stem Cells Can Successfully Differentiate into Ventricular Cardiomyocytes

Ventricular cardiomyocytes were generated from iPSCdirect™ SCTi003-A cells using STEMdiff™ Ventricular Cardiomyocyte Differentiation Kit (Catalog #05010). (A) 48 hours after thawing and plating in mTeSR™ Plus and CloneR™2, iPSCdirect™ cells reached the desired confluency and are ready for Day 0 of differentiation according to the STEMdiff™ Ventricular Cardiomyocyte Product Information Sheet. (B) By Day 15 of differentiation, monolayer cultures show iPSC-derived ventricular cardiomyocytes that (C) exhibit coordinated beating behavior.

Microscopy image of Day 21 hepatocyte-like cells and quantification of hepatic gene expression markers ALB and A1AT

Figure 8. iPSCdirect™ SCTi003-A Human Pluripotent Stem Cells Can Successfully Differentiate into Hepatocytes

iPSCdirect™ SCTi003-A cells were plated according to the iPSCdirect™ Product Information Sheet, in preparation for Day 1 of the STEMdiff™ Hepatocyte Kit (Catalog #100-0520) protocol outlined in the STEMdiff™ Hepatocyte Kit Product Information Sheet. (A) Monolayers of hepatocyte-like cells with characteristic polygonal morphology and binucleation are apparent by Day 21 of differentiation. (B) Marker expression was quantified by flow cytometry for hepatic markers albumin (ALB) and alpha1-antitrypsin (A1AT). Error bars represent standard deviation (n = 3 biological replicates).

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Catalog #
200-0510
Lot #
All
Language
English
Catalog #
100-1028
Lot #
All
Language
English

Applications

This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.